Secondary stroke prevention

被引:258
作者
Hankey, Graeme J. [1 ,2 ]
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia
[2] Sir Charles Gairdner Hosp, Dept Neurol, Nedlands, WA 6009, Australia
关键词
TRANSIENT ISCHEMIC ATTACK; DENSITY-LIPOPROTEIN CHOLESTEROL; PATENT FORAMEN OVALE; HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; PERCUTANEOUS CORONARY INTERVENTION; ATRIAL-FIBRILLATION PATIENTS; HORMONE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED-TRIAL; NET CLINICAL BENEFIT; LOW-INCOME COUNTRIES;
D O I
10.1016/S1474-4422(13)70255-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is often more severe and disabling than the index event. Optimum secondary prevention of recurrent stroke needs rapid diagnosis and treatment and prompt identification of the underlying cardiovascular cause. Effective treatments include organised acute assessment and intervention with antithrombotic therapy, carotid revascularisation, and control of causal risk factors, as appropriate. However, effective treatments are not implemented optimally in clinical practice. Recurrent strokes continue to account for 25-30% of all strokes and represent unsuccessful secondary prevention. Immediate and sustained implementation of effective and appropriate secondary prevention strategies in patients with first-ever stroke or transient ischaemic attack has the potential to reduce the burden of stroke by up to a quarter.
引用
收藏
页码:178 / 194
页数:17
相关论文
共 169 条
[1]  
Aburto NJ., 2013, BMJ-BRIT MED J, V346, pF1378
[2]   MRI findings and stroke risk in TIA patients with different symptom durations [J].
Al-Khaled, Mohamed ;
Eggers, Juergen .
NEUROLOGY, 2013, 80 (21) :1920-1926
[3]   Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin A Systematic Review and Meta-analysis [J].
Albertsen, Ida Ehlers ;
Rasmussen, Lars Hvilsted ;
Overvad, Thure Filskov ;
Graungaard, Tina ;
Larsen, Torben Bjerregaard ;
Lip, Gregory Y. H. .
STROKE, 2013, 44 (05) :1329-+
[4]   Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin [J].
Algra, A ;
Van Gijn, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02) :255-255
[5]   Recurrent cerebral ischemia in medically treated patent foramen ovale A meta-analysis [J].
Almekhlafi, M. A. ;
Wilton, S. B. ;
Rabi, D. M. ;
Ghali, W. A. ;
Lorenzetti, D. L. ;
Hill, M. D. .
NEUROLOGY, 2009, 73 (02) :89-97
[6]   Factors influencing haemorrhagic transformation in ischaemic stroke [J].
Alvarez-Sabin, Jose ;
Maisterra, Olga ;
Santamarina, Estevo ;
Kase, Carlos S. .
LANCET NEUROLOGY, 2013, 12 (07) :689-705
[7]   Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack - The stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial [J].
Amarenco, Pierre ;
Goldstein, Larry B. ;
Szarek, Michael ;
Sillesen, Henrik ;
Rudolph, Amy E. ;
Callahan, Alfred, III ;
Hennerici, Michael ;
Simunovic, Lisa ;
Zivin, Justin A. ;
Welch, K. Michael A. .
STROKE, 2007, 38 (12) :3198-3204
[8]   Patients With Transient Ischemic Attack With ABCD2 <4 Can Have Similar 90-Day Stroke Risk as Patients With Transient Ischemic Attack With ABCD2 ≥4 [J].
Amarenco, Pierre ;
Labreuche, Julien ;
Lavallee, Philippa C. .
STROKE, 2012, 43 (03) :863-865
[9]   Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention [J].
Amarenco, Pierre ;
Labreuche, Julien .
LANCET NEUROLOGY, 2009, 8 (05) :453-463
[10]   Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial [J].
Amarenco, Pierre ;
Goldstein, Larry B. ;
Messig, Michael ;
O'Neill, Blair J. ;
Callahan, Alfred, III ;
Sillesen, Henrik ;
Hennerici, Michael G. ;
Zivin, Justin A. ;
Welch, K. M. A. .
STROKE, 2009, 40 (07) :2486-2492